Nova Eye USA Sales Growth Opportunity
Important Notice and Disclaimer
This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE) (Nova Eye or Company). While the information in
this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is
made as to the accuracy, adequacy or reliability of any statement, estimates, opinions or other information contained in the
presentation. The information in this presentation is of a general nature and does not purport to be complete nor does it contain all
information which a prospective investor may require in evaluating a possible investment in Nova Eye or that would be required in a
prospectus, or a product disclosure statement prepared in accordance with the requirements of the Corporations Act.
Future performance
This presentation may contain forward looking statements. These forward-looking statements have been made based upon Nova
Eye's expectations, assumptions and beliefs concerning future developments and their potential effect on Nova Eye (and its
controlled entities), based on information currently available to management as at the date of this presentation. These forward-
looking statements are subject to risks, stakeholder engagement, assumptions and uncertainty which are, in many instances,
beyond Nova Eye's control. Further information regarding the key risks associated with investment are located on slides 34-40 of
this presentation and you should consider these risks carefully. While Nova Eye believes that the expectations reflected in the
forward-looking statements in this presentation are reasonable, neither Nova Eye not its directors or any other person named in the
presentation can assure you that such expectations will prove to be correct or that implied results will be achieved. These forward-
looking statements do not constitute any representation as to future performance and should not be relied upon as financial advice
of any nature. Any forward-looking statement contained in this document is qualified by this cautionary statement.
Not an offer
This presentation does not constitute an offer to sell or a solicitation or an offer to purchase any security or financial product or
service and is not a prospectus, product disclosure statement or other offering document under Australian law (and will not be
lodged with ASIC) or any other law. This presentation is for information purposes only and is not an invitation or offer of securities
for subscription, purchase or sale in any jurisdiction.
Not financial product advice
This presentation does not constitute financial product or investment advice or any recommendation to acquire new shares or
accounting, legal or tax advice. It has been prepared without taking into account the objectives, financial or tax situation or needs of
individuals. Before making an investment decision, prospective investors should consider the appropriateness of the information
having regard to their own objectives, financial and tax situation and needs and obtain legal and taxation advice appropriate to their
jurisdiction.
Disclaimer
To the maximum extent permitted by law, neither Nova Eye nor its related bodies corporate, directors, officers, employees or
agents, nor any other person, accepts any liability, including, without limitation, any liability arising from fault or negligence, for any
loss arising from the use of this presentation or its contents or otherwise arising in connection with it. Nova Eye is under no
obligation to release any updates or revisions to tis presentation to reflect any change in expectation or assumptions and disclaim
all responsibility and liability for these forward-looking statements (including, without limitation, liability for fraud or negligence).
pupil
suspensory ligament
iris
anterior chamber
cornea
lens
sclera
lateral rectus muscle
medial rectus muscle
choroid
vitreous body
retina
ne
macula lutea
fovea centralis
(central depression)
optic nerve
optic disc
(blind spot)
nova-eye.com | 2View entire presentation